title: Warfarin pharmacogenomics and African ancestry.
abstract: In this issue of Blood, Limdi and coauthors demonstrate that racially informed warfarin pharmacogenetic algorithms perform better than traditional algorithms, which previously excluded genetic variants that are unique to patients with African ancestry.
authors.affiliation: UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES.
authors.forename: Elvin T
authors.identifier: http://orcid.org/0000-0001-7991-6430
authors.initials: ET
authors.lastname: Price
mesh_terms: D065729:Cytochrome P-450 CYP2C9 / Q000235:genetics*; D003577:Cytochrome P-450 Enzyme System / Q000235:genetics*; D005260:Female; D006801:Humans; D008297:Male; D010597:Pharmacogenetics; D011110:Polymorphism, Genetic / Q000235:genetics*; D044469:Racial Groups / Q000235:genetics*; D054556:Venous Thromboembolism / Q000235:genetics*; D064417:Vitamin K Epoxide Reductases / Q000235:genetics*; D014859:Warfarin / Q000008:administration & dosage*
chemical_list: D014859:Warfarin; D003577:Cytochrome P-450 Enzyme System; D065729:Cytochrome P-450 CYP2C9; D064417:Vitamin K Epoxide Reductases